| 1 | Stigma in leprosy: concepts, causes and determinants (10.47276/lr.85.1.36) | Abstract References ORCID License | 208.64 | 121 |
| 2 | Leprosy Type 1 (reversal) reactions and their management (10.47276/lr.79.4.372) | Abstract References ORCID License | 206.45 | 115 |
| 3 | Current knowledge on Mycobacterium leprae transmission: a sy… (10.47276/lr.86.2.142) | Abstract References ORCID License | 206.07 | 114 |
| 4 | The biology of nerve injury in leprosy (10.47276/lr.79.3.242) | Abstract References ORCID License | 203.74 | 108 |
| 5 | The role of thalidomide in the management of erythema nodosu… (10.47276/lr.78.3.197) | Abstract References ORCID License | 203.34 | 107 |
| 6 | Leprosy in wild armadillos (10.47276/lr.76.3.198) | Abstract References ORCID License | 199.12 | 97 |
| 7 | WHO disability grading: operational definitions (10.47276/lr.74.4.366) | Abstract References ORCID License | 195.42 | 89 |
| 8 | The INFIR Cohort Study: investigating prediction, detection… (10.47276/lr.76.1.14) | Abstract References ORCID License | 195.42 | 89 |
| 9 | Risk factors for the development of clinical leprosy among c… (10.47276/lr.75.4.310) | Abstract References ORCID License | 191.38 | 81 |
| 10 | Curing the stigma of leprosy (10.47276/lr.76.2.119) | Abstract References ORCID License | 191.38 | 81 |
| 11 | Risk factors for developing leprosy – a population-based coh… (10.47276/lr.77.1.48) | Abstract References ORCID License | 189.76 | 78 |
| 12 | Immunoprophylactic effects of the anti-leprosy Mw vaccine in… (10.47276/lr.76.2.127) | Abstract References ORCID License | 186.33 | 72 |
| 13 | The Role of Mycobacterium leprae Phenolic Glycolipid I (PGL-… (10.47276/lr.82.4.344) | Abstract References ORCID License | 186.33 | 72 |
| 14 | Drug-resistant leprosy: Monitoring and current status (10.47276/lr.83.3.269) | Abstract References ORCID License | 184.51 | 69 |
| 15 | Role of contact tracing and prevention strategies in the int… (10.47276/lr.85.1.2) | Abstract References ORCID License | 181.95 | 65 |
| 16 | Gender and leprosy: case studies in Indonesia, Nigeria, Nepa… (10.47276/lr.80.1.65) | Abstract References ORCID License | 180.62 | 63 |
| 17 | The mouse foot-pad technique for cultivation of Mycobacteriu… (10.47276/lr.77.1.5) | Abstract References ORCID License | 179.93 | 62 |
| 18 | STEP: An intervention to address the issue of stigma related… (10.47276/lr.76.4.316) | Abstract References ORCID License | 179.24 | 61 |
| 19 | The impact of leprosy control on the transmission of M. lepr… (10.47276/lr.78.4.330) | Abstract References ORCID License | 179.24 | 61 |
| 20 | The frequency of drug resistance mutations in Mycobacterium… (10.47276/lr.78.4.343) | Abstract References ORCID License | 179.24 | 61 |
| 21 | Comparison of three immunological tests for leprosy diagnosi… (10.47276/lr.82.4.389) | Abstract References ORCID License | 177.09 | 58 |
| 22 | Leprosy: a review on elimination, reducing the disease burde… (10.47276/lr.86.4.307) | Abstract References ORCID License | 176.34 | 57 |
| 23 | Diffuse leprosy of Lucio and Latapí: a histologic study (10.47276/lr.78.3.248) | Abstract References ORCID License | 175.59 | 56 |
| 24 | The epidemiological behaviour of leprosy in Brazil (10.47276/lr.80.3.332) | Abstract References ORCID License | 175.59 | 56 |
| 25 | Genetics of host response in leprosy (10.47276/lr.77.3.189) | Abstract References ORCID License | 172.43 | 52 |
| 26 | Comparison of PCR mediated amplification of DNA and the clas… (10.47276/lr.74.1.18) | Abstract References ORCID License | 171.60 | 51 |
| 27 | Depressive status of leprosy patients in Bangladesh: associa… (10.47276/lr.75.1.57) | Abstract References ORCID License | 171.60 | 51 |
| 28 | The INFIR Cohort Study: assessment of sensory and motor neur… (10.47276/lr.76.4.277) | Abstract References ORCID License | 171.60 | 51 |
| 29 | Multi-centre, double blind, randomized trial of three steroi… (10.47276/lr.77.1.25) | Abstract References ORCID License | 171.60 | 51 |
| 30 | A study on transmission and a trial of chemoprophylaxis in c… (10.47276/lr.75.4.376) | Abstract References ORCID License | 165.32 | 44 |
| 31 | The relationship between detection delay and impairment in l… (10.47276/lr.77.4.356) | Abstract References ORCID License | 164.35 | 43 |
| 32 | The role of free-living pathogenic amoeba in the transmissio… (10.47276/lr.79.4.401) | Abstract References ORCID License | 164.35 | 43 |
| 33 | Anti-PGL-I seroepidemiology in leprosy cases: household cont… (10.47276/lr.82.4.358) | Abstract References ORCID License | 163.35 | 42 |
| 34 | Trends in leprosy case detection worldwide since 1985 (10.47276/lr.75.1.19) | Abstract References ORCID License | 162.32 | 41 |
| 35 | Adverse effects from Multi-drug therapy in leprosy: a Brazil… (10.47276/lr.78.3.216) | Abstract References ORCID License | 162.32 | 41 |
| 36 | Impact of socio-economic development, contact and peer couns… (10.47276/lr.88.1.2) | Abstract References ORCID License | 161.28 | 40 |
| 37 | Childhood leprosy in an urban clinic, Hyderabad, India: clin… (10.47276/lr.73.3.248) | Abstract References ORCID License | 160.21 | 39 |
| 38 | Patient-related factors predicting the effectiveness of rifa… (10.47276/lr.83.3.292) | Abstract References ORCID License | 160.21 | 39 |
| 39 | How to reduce stigma in leprosy – a systematic literature re… (10.47276/lr.85.3.149) | Abstract References ORCID License | 160.21 | 39 |
| 40 | Social stigma: a comparative qualitative study of integrated… (10.47276/lr.73.2.186) | Abstract References ORCID License | 159.11 | 38 |
| 41 | Postgenomic Mycobacterium leprae antigens for cellular and s… (10.47276/lr.82.4.402) | Abstract References ORCID License | 159.11 | 38 |
| 42 | Cultural validation of a new instrument to measure leprosy-r… (10.47276/lr.88.1.23) | Abstract References ORCID License | 157.98 | 37 |
| 43 | Eye disease in multibacillary leprosy patients at the time o… (10.47276/lr.73.3.225) | Abstract References ORCID License | 156.82 | 36 |
| 44 | Molecular detection of drug resistance in Mycobacterium lepr… (10.47276/lr.75.2.118) | Abstract References ORCID License | 156.82 | 36 |
| 45 | Delay in the diagnosis of leprosy in the Metropolitan Region… (10.47276/lr.77.1.41) | Abstract References ORCID License | 156.82 | 36 |
| 46 | Prevalence of mental distress in the outpatient clinic of a… (10.47276/lr.75.4.367) | Abstract References ORCID License | 155.63 | 35 |
| 47 | The ML Flow test as a point of care test for leprosy control… (10.47276/lr.78.1.70) | Abstract References ORCID License | 155.63 | 35 |
| 48 | Childhood leprosy in a tertiary-care hospital in Delhi, Indi… (10.47276/lr.82.3.259) | Abstract References ORCID License | 155.63 | 35 |
| 49 | Serum cytokine profile in leprosy and its correlation with c… (10.47276/lr.82.4.371) | Abstract References ORCID License | 155.63 | 35 |
| 50 | Treatment with corticosteroids of long-standing nerve functi… (10.47276/lr.74.4.311) | Abstract References ORCID License | 154.41 | 34 |